Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HyOrc Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2009
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
FY2025
FY2025
Revenue
0.62
0.06
General and administrative
0.07
0.09
0.07
0.04
0.03
0.04
0
1.02
0.32
Operating expenses
0.18
0.24
0.19
0.29
0.13
0.96
2.25
0.62
Operating income
-0.18
-0.24
-0.19
-0.29
-0.13
-1.63
-0.57
Pre-tax income
-0.96
-0.03
Net income
-0.11
-0.18
-0.24
-0.19
-0.81
-0.13
-0.96
-0.03
-1.63
-0.55
EBITDA
-1.63
-0.57
EPS, basic
-0.01
-0.01
-0.00
-0.02
-0.00
-0.01
-0.00
0.00
0.00
EPS, diluted
-0.01
-0.01
-0.00
-0.02
-0.00
-0.01
-0.00
0.00
0.00
Shares, basic (weighted)
56.7
38.4
38.4
39.3
42.2
67.2
67.2
686
733
Shares, diluted (weighted)
56.7
38.4
38.4
39.3
42.2
67.2
67.2
686
733
Balance sheet
FY2009
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
FY2025
FY2025
Cash and equivalents
0
0
0.01
0
0.01
0
0
0
0.18
0.02
Receivables
0.04
Total current assets
0
0.01
0
0.01
0
0
0.18
0.06
Property, plant and equipment
2.32
Goodwill
15.8
15.8
Other non-current assets
2.7
2.32
Total assets
0
0.64
0.63
0.01
0
0
0
22.2
21.7
Accounts payable
0.03
0.13
0.15
0.03
0.02
0.02
0.02
0.16
0.02
Accrued liabilities
0.01
0.02
0.04
Short-term debt
0.04
0.02
0
0
Total current liabilities
0.7
1.07
1.26
1.27
1.34
0.28
0.31
0.02
Total liabilities
0.75
1.07
1.26
1.27
1.34
0.28
0.31
0.16
0.02
Paid-in capital
2.57
3.12
3.12
3.29
3.67
5.67
5.67
29.6
29.6
Retained earnings
3.92
4.11
4.92
-5.05
-6.01
-6.05
-8.22
-8.77
Shareholders' equity
-0.62
-0.75
-0.44
-0.63
-1.27
-1.33
-0.28
-0.31
22.1
21.7
Total equity
-0.62
-0.75
-0.44
-0.63
-1.27
-1.33
-0.28
-0.31
22.1
21.7
Total liabilities and equity
0
0.64
0.63
0.01
0
0
0
22.2
21.7
Shares outstanding
56.7
38.4
38.4
41.9
43.2
67.2
67.2
728
737
Cash flow statement
FY2009
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
FY2025
FY2025
Net income
-0.11
-0.18
-0.24
-0.19
-0.81
-0.13
-0.96
-0.03
-1.63
-0.55
Depreciation and amortization
0
0
Stock-based compensation
0.03
Deferred income tax
0
0
Change in receivables
-0.05
Change in payables
-0.01
0.11
0.01
0
-0.02
-0.01
0
0.05
-0.15
Cash from operations
-0
0.01
-0.18
-0.11
-0.08
-0.19
-0.01
-0.35
-0.34
Cash from investing
0.01
Debt repaid
-0
-0
0.01
-0
Stock issued
0.06
Cash from financing
-0
-0
0.18
0.11
0.08
0.19
0.01
0.17
Net change in cash
-0
-0
-0.35
-0.16
Interest paid
0.01
0.01
0.01
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.08 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-957.0%
Operating income / revenue.
EBITDA margin
-957.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-932.4%
Net income / revenue.
Operating cash flow margin
-568.4%
Cash from operations / revenue.
Return on equity (ROE)
-2.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.5%
Net income / average total assets.
Return on invested capital (ROIC)
-2.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
46.4%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
0.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-90.4%
Revenue vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-1.6%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-2.2%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
7.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.73x
Current assets / current liabilities.
Quick ratio
3.73x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.29x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.00
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
$0.03
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1,023x
Market cap / revenue.
P/B
2.78x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
10.1x
Market cap / tangible book value, when positive.
EV/Sales
1,023x
Enterprise value / revenue.
Earnings yield
-0.9%
Net income / market cap (the inverse of P/E).
What was HyOrc Corp's revenue in fiscal 2025?
HyOrc Corp reported revenue of $59.1K for fiscal 2025, 90.4% lower than the year before.
Was HyOrc Corp profitable in fiscal 2025?
No. It reported a net loss of $551.3K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.